These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 2566639)
1. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin. Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms]. Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349 [TBL] [Abstract][Full Text] [Related]
3. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125]. Kobayashi H Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):828-34. PubMed ID: 3166483 [TBL] [Abstract][Full Text] [Related]
4. [The clinical value of sialyl SSEA-1 antigen in patients with gynecologic tumors]. Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saitoh J; Ueda G; Tanizawa O; Kimura T; Kawata M; Taniguchi T Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2120-4. PubMed ID: 2892886 [TBL] [Abstract][Full Text] [Related]
5. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers]. Kataoka A; Yakushiji M Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782 [TBL] [Abstract][Full Text] [Related]
6. [Significance of tumor markers in the treatment of patients with ovarian malignancies]. Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293 [TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group]. Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400 [TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of serum sialyl SSEA-1 antigen in obstetrical and gynecological patients]. Tanaka T; Iwasaka T; Hayashi Y; Hachisuga T; Yokoyama M; Ohkuma Y; Matsuo N; Fukuda K; Sugimori H Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1157-61. PubMed ID: 1975831 [TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of serum sialyl Tn antigen levels in patients with gynecologic tumors]. Shimizu C; Inoue M; Ogawa H; Ueda G; Tanizawa O Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1537-42. PubMed ID: 2273309 [TBL] [Abstract][Full Text] [Related]
10. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor. Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294 [TBL] [Abstract][Full Text] [Related]
11. [Field trial for the early detection of patients with ovarian cancer--discrimination of ovarian cancer patients by the statistical analysis using Mahalanobis' generalized distance]. Kobayashi H; Sumimoto K; Terao T; Kawashima Y; Okada K Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):174-80. PubMed ID: 1372032 [TBL] [Abstract][Full Text] [Related]
12. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma]. Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884 [TBL] [Abstract][Full Text] [Related]
13. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers]. Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666 [TBL] [Abstract][Full Text] [Related]
14. [The clinical value of tissue polypeptide antigen in ovarian carcinoma]. Wu L; Sun J; Wang X Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer]. Kobayashi H; Sumimoto K; Terao T; Kawashima Y Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640 [TBL] [Abstract][Full Text] [Related]
16. Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer. Yabushita H; Masuda T; Ogawa A; Noguchi M; Ishihara M Gynecol Oncol; 1988 Jan; 29(1):66-75. PubMed ID: 3422208 [TBL] [Abstract][Full Text] [Related]
17. [Field trial of the early detection in patients with ovarian cancer]. Kobayashi H; Sumimoto K; Terao T; Kawashima Y; Kouda M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1743-9. PubMed ID: 2480393 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of sialyl Tn antigen in patients with gynecologic tumors. Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]